ECOG: The Eastern Cooperative Oncology Group

ECOG Protocols Active as of 05/24/13

Click on the protocol number to view the NCI's PDQ description of the protocol.


MYELOMA COMMITTEE


ProtocolTitle
BMTCTN0702 A Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma
Activation Date: 10-jun-2010
E1A10 A Randomized Phase I/II Study of Bortezomib, Rituximab, Dexamethasone and Temsirolimus in Patients with Relapsed Waldenstrom's Macroglobulinemia and Relapsed/Refractory Mantle Cell, Follicular, Marginal Zone or Small Lymphocytic Lymphomas (Phase I), and Untreated/Relapsed Waldenstrom's Macroglobulinemia (PhaseII)
Activation Date: 20-jul-2011 Suspended: 23-may-2013
ECOG Participants(requires Adobe Acrobat)
E3A05 Ancillary Laboratory Protocol for Collecting Diagnostic Material on Patients Considered for Studies of Plasma Cell Disorders
Activation Date: 30-aug-2006
ECOG Participants(requires Adobe Acrobat)
E3A06 Randomized Phase III Trial of Lenalidomide versus Observation Alone in Patients with Asymptomatic High-Risk Smoldering Multiple Myeloma
Activation Date: 05-oct-2010

ECOG Home Page


How to contact ECOG

All contents copyright © 1998 Eastern Cooperative Oncology Group.
All rights reserved.
Revised: 05/24/13